[Newly recognized side-effects of proton pump inhibitors. Arguments in favour of fundoplication for GERD?].

作者: B.H.A. von Rahden , M. Scheurlen , J. Filser , H.J. Stein , C.-T. Germer

DOI: 10.1007/S00104-011-2173-X

关键词:

摘要: Among other indications proton pump inhibitors (PPIs) are used as medical treatment of gastroesophageal reflux disease (GERD) and the most frequently prescribed drugs in gastroenterology. Until recently PPIs were regarded very safe associated with few side-effects. However, during recent years study results have revealed many severe adverse events especially long-term PPI use. We review currently available evidence, regarding side-effects discuss potential impact on strategies for GERD (conservative vs. antireflux surgery). Currently data suggest that osteoporosis-related fractures, Clostridium difficile diarrhea (CDAD), community hospital-acquired pneumonia, pharmacologic interaction clopidogrel acetylsalicylic acid subsequent increased rate cardiovascular events, refractory hypomagnesemia rebound symptoms etc. The risk-benefit ratio is increasingly recognized being less favourable. This leads to a more critical viewpoint raises question whether may outweigh benefits, seem make strong argument favour laparoscopic fundoplication GERD.

参考文章(48)
Emmanuel Andrès, Esther Noel, Meher Ben Abdelghani, Vitamin B12 Deficiency Associated with Chronic Acid Suppression Therapy Annals of Pharmacotherapy. ,vol. 37, pp. 1730- 1730 ,(2003) , 10.1345/APH.1D189
Mohammed Aseeri, Todd Schroeder, Joan Kramer, Rosalee Zackula, Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. The American Journal of Gastroenterology. ,vol. 103, pp. 2308- 2313 ,(2008) , 10.1111/J.1572-0241.2008.01975.X
Deepak L. Bhatt, Byron L. Cryer, Charles F. Contant, Marc Cohen, Angel Lanas, Thomas J. Schnitzer, Thomas L. Shook, Pablo Lapuerta, Mark A. Goldsmith, Loren Laine, Benjamin M. Scirica, Sabina A. Murphy, Christopher P. Cannon, Clopidogrel with or without Omeprazole in Coronary Artery Disease The New England Journal of Medicine. ,vol. 363, pp. 1909- 1917 ,(2010) , 10.1056/NEJMOA1007964
Maarten A.C. Broeren, Hypomagnesemia Induced by Several Proton-Pump Inhibitors Annals of Internal Medicine. ,vol. 151, pp. 755- 756 ,(2009) , 10.7326/0003-4819-151-10-200911170-00016
Mette Charlot, Ole Ahlehoff, Mette Lykke Norgaard, Casper H Jørgensen, Rikke Sørensen, Steen Z Abildstrøm, Peter Riis Hansen, Jan Kyst Madsen, Lars Køber, Christian Torp-Pedersen, Gunnar Gislason, Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use: A Nationwide Cohort Study Annals of Internal Medicine. ,vol. 153, pp. 378- 386 ,(2010) , 10.7326/0003-4819-153-6-201009210-00005
M. Charlot, E. L. Grove, P. R. Hansen, J. B. Olesen, O. Ahlehoff, C. Selmer, J. Lindhardsen, J. K. Madsen, L. Kober, C. Torp-Pedersen, G. H. Gislason, Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study BMJ. ,vol. 342, ,(2011) , 10.1136/BMJ.D2690
Jean-Baptiste Esteve, Johanne Silvain, Laurent Payot, Delphine Brugier, Guillaume Cayla, Farzin Beygui, Gilbert Bensimon, Christian Funck-Brentano, Gilles Montalescot, Jean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, Eric Villard, Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study The Lancet. ,vol. 373, pp. 309- 317 ,(2009) , 10.1016/S0140-6736(08)61845-0
Debasish Das, Andrew P. Chilton, Janusz A. Jankowski, Chemoprevention of Oesophageal Cancer and the AspECT Trial Cancer Prevention II. ,vol. 181, pp. 161- 169 ,(2009) , 10.1007/978-3-540-69297-3_15
Menzies D. Dial S, Alrasadi K, Manoukian C, Huang A, Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies Canadian Medical Association Journal. ,vol. 171, pp. 33- 38 ,(2004) , 10.1503/CMAJ.1040876
Sandra Dial, JAC Delaney, Alan N Barkun, Samy Suissa, Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile–Associated Disease JAMA. ,vol. 294, pp. 2989- 2995 ,(2005) , 10.1001/JAMA.294.23.2989